Membership-based villages help arrange services for seniors — such as handyman help or transportation to appointments — and provide social connections through classes, leisure opportunities, or community events. Despite great promise, they have been slow to expand because of difficulties raising funding and keeping people interested.
Medicare has proposed limiting coverage of Aduhelm, the costly new drug to treat Alzheimer’s disease, and several prominent groups representing patients and their families are pressing the program to make it more widely available. But among individuals facing the disease, the outlook is more nuanced.
The spread of the omicron variant has dashed the hopes of many older adults that the country was exiting the worst of the pandemic, leaving them anxious while their patience wears thin.
Home health and hospice agencies are experiencing extreme worker shortages, which means they can’t provide services to all the patients seeking care.
Relatives say it is important they be allowed to go into nursing homes because staff shortages are affecting care. And many are still upset about lengthy separations from loved ones during lockdowns earlier in the pandemic.
Muchos familiares dicen que no pueden conseguir las pruebas ante la enorme demanda y la escasez de suministros, lo que les impide ver a sus seres queridos.
Prominent researchers say the nationwide effort to get people to spell out how they want to be treated as they die is not improving patients’ care.
Fear of covid has kept some adults from moving to nursing homes, and many facilities are in trouble financially. When Nevada, Missouri, officials announced they were planning to close a home specializing in dementia care, members of the community rose up in protest.
The loss of smell is a common issue for many seniors and is often overlooked. Yet it can have serious consequences.
Dr. Susan Massad created a “health team” after learning she had metastatic breast cancer. These friends and family members help her make difficult decisions and lead the most fulfilling life possible.
In light of the pandemic’s shocking death toll among seniors, organizations are trying new strategies to help older Americans get better care.
Las experiencias de Whitney revelan la discriminación por edad en los entornos de atención médica, un problema de larga data que está recibiendo nueva atención durante la pandemia de covid, que ha matado a más de medio millón de estadounidenses de 65 años y más.
Ageism in health care settings, which can result in inappropriate or dangerous treatment, is getting new attention during the covid pandemic, which has killed more than half a million Americans age 65 and older.
Long-term relationships between patients and doctors often enrich the quality of care and create deep emotional bonds. When the doctors retire or move on, saying goodbye can be hard.
The condition can be an early signal of Alzheimer’s disease, but not always. Other health concerns could be causing thinking or memory problems, and the new drug, Aduhelm, would not be appropriate for those patients.
Lynn Casteel Harper, a minister at the interdenominational Riverside Church in New York City, discusses the spiritual dimension of aging.
The latest research shows that although deaths in nursing homes received enormous attention, far more older adults who perished from covid lived outside of institutions. People with dementia and other severe neurological conditions, chronic kidney disease and immune deficiencies were hit especially hard.
Relationships with people you know only superficially can help develop a sense of belonging and provide motivation to engage in activities. Research has found that older adults who have a broad array of “weak” as well as “close” ties enjoy better physical and psychological well-being and live longer than people with less diverse social networks.
Mientras médicos y expertos en políticas de salud debaten los méritos de Aduhelm, el primer fármaco para el Alzheimer aprobado en 18 años, los pacientes simplemente quieren saber: “¿me ayudará?”.
The potential benefits of Aduhelm are small, its effectiveness is not certain, and even the FDA Thursday shifted its guidance on who should get the drug. But physicians are dealing with an onslaught of interest from patients and their families, and figuring out which patients are best positioned to be helped by the drug will be difficult.